Closed
SectorHealthcare
301.51 0.6
24h
Min
292.63
Max
310.36
Income | -14M -73M |
---|---|
Sales | 34M 137M |
EPS | -3.32 |
Profit margin | -53.361 |
Employees | 528 |
EBITDA | -14M -70M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +42.56% upside |
Next Earnings | 6 sie 2025 |
---|
Market Cap | -595M 6.7B |
---|---|
Previous open | 300.91 |
Previous close | 301.51 |
By Acuity
50%
50%
163 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 427.91 USD 42.56%
High 540 USD
Low 248 USD
Based on 13 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$